Scott Schliebner is a strategic and innovative drug development executive with 30 years of experience across the biopharma, contract research organization (CRO), and non-profit sectors. Passionate about ensuring the patient voice is incorporated into drug development, Scott emphasizes patient-focused solutions to reduce the burden of clinical trial participation and accelerate drug development. Scott serves as a Strategic and Commercial Advisor, belongs to several industry-led Scientific Advisory Boards, and holds Board Member roles within the non-profit space. He regularly speaks on topics such as patient-focused drug development, innovative regulatory strategies, novel approaches to clinical development, and multi-stakeholder collaboration. Scott received a Master’s Degree in Public Health from the University of Utah School of Medicine and completed a Graduate Research Fellowship at The National Institutes of Health/NINDS. He lives with his family in Seattle, WA and tries to ski as much as possible.
